U.S. Congress

221 - 240 of 986 Results

  • What the Health? From 麻豆女优 Health News

    A Year Without Roe

    Episode 304

    It鈥檚 been a year since the Supreme Court overturned Roe v. Wade and, with it, the nationwide right to abortion. The decision in Dobbs v. Jackson Women鈥檚 Health Organization set off widespread uncertainty in government and the courts about the legality or illegality of the procedure. But the decision has had other consequences too, including affecting where health professionals choose to locate. In this special episode of 麻豆女优 Health News鈥 鈥淲hat the Health?鈥 Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join 麻豆女优 Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews 麻豆女优鈥檚 Alina Salganicoff about the organization鈥檚 research and other work on women鈥檚 health policy over the past year.

    Listen Now
  • What the Health? From 麻豆女优 Health News

    Slow Your Disenroll

    Episode 302

    More than a million Americans have lost Medicaid coverage since pandemic protections ended. The Biden administration is asking states to slow disenrollment, but that does not mean states must listen. Meanwhile, a Supreme Court decision gives Medicaid beneficiaries the right to sue over their care, and a new deal preserves coverage of preventive services nationwide as a Texas court case continues. Rachel Cohrs of Stat, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join 麻豆女优 Health News鈥 Mary Agnes Carey to discuss these issues and more. Also this week, 麻豆女优 Health News鈥 Julie Rovner interviews Dan Mendelson, CEO of Morgan Health, a new unit of JPMorgan Chase, about employers鈥 role in insurance coverage.

    Listen Now
  • What the Health? From 麻豆女优 Health News

    Debt Deal Leaves Health Programs (Mostly) Intact

    Episode 301

    The bipartisan deal to extend the U.S. government鈥檚 borrowing authority includes future cuts to federal health agencies, but they are smaller than many expected and do not touch Medicare and Medicaid. Meanwhile, Merck & Co. becomes the first drugmaker to sue Medicare officials over the federal health insurance program鈥檚 new authority to negotiate drug prices. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Lauren Weber of The Washington Post, and Jessie Hellmann of CQ Roll Call join 麻豆女优 Health News鈥 chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews 麻豆女优 Health News senior correspondent Sarah Jane Tribble, who reported the latest 麻豆女优 Health News-NPR 鈥淏ill of the Month鈥 feature, about the perils of visiting the U.S. with European health insurance.

    Listen Now
  • What the Health? From 麻豆女优 Health News

    When an Anti-Vaccine Activist Runs for President

    Episode 299

    Robert F. Kennedy Jr.鈥檚 official entry into the presidential race poses a thorny challenge for journalists: how to cover a candidate who鈥檚 opposed to vaccines without amplifying misinformation. And South Carolina becomes the latest state in the South to ban abortion after roughly six weeks of pregnancy. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join 麻豆女优 Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews 麻豆女优 Health News senior correspondent Aneri Pattani about her project to track the billions of dollars coming from opioid makers to settle lawsuits.

    Listen Now
  • What the Health? From 麻豆女优 Health News

    The Abortion Pill Goes Back to Court

    Episode 298

    A three-judge appeals court panel heard testimony this week about revoking the FDA鈥檚 22-year-old approval of a key pill used in medication abortion and miscarriage management. The judges all have track records of siding with abortion foes. Meanwhile, as the standoff over raising the federal debt ceiling continues in Washington, a major sticking point is whether to impose work requirements on recipients of Medicaid coverage. Victoria Knight of Axios, Rachel Roubein of The Washington Post, and Sandhya Raman of CQ Roll Call join 麻豆女优 Health News chief Washington correspondent Julie Rovner to discuss these issues and more.

    Listen Now
  • What the Health? From 麻豆女优 Health News

    Dancing Under the Debt Ceiling

    Episode 295

    House Republicans passed their plan to raise the nation鈥檚 debt ceiling, along with major cuts to health (and other domestic) programs. Unlikely to become law, it calls for new work requirements for adults on Medicaid. Meanwhile, state efforts targeting trans people bear a striking resemblance to the fight against abortion rights. Jessie Hellmann of CQ Roll Call, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join 麻豆女优 Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Renuka Rayasam, who reported the latest 麻豆女优 Health News-NPR 鈥淏ill of the Month鈥 feature, about a specialist鈥檚 demand to be paid as much as $15,000 before treating a woman鈥檚 serious pregnancy complication.

    Listen Now
  • What the Health? From 麻豆女优 Health News

    Will They or Won鈥檛 They (Block the Abortion Pill)?

    Episode 294

    The Supreme Court is considering the future of the abortion pill mifepristone, after GenBioPro sued the FDA over limitations that effectively block generic production of the drug, a major part of the market. Congress is considering proposals that would impose Medicaid work requirements, crack down on pharmacy benefit managers, and more. And President Joe Biden moved to expand health coverage to young immigrants known as 鈥淒reamers.鈥 Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join 麻豆女优 Health News鈥 Mary Agnes Carey to discuss these issues and more.

    Listen Now
  • What the Health? From 麻豆女优 Health News

    The Confusing Fate of the Abortion Pill

    Episode 293

    The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA鈥檚 approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join 麻豆女优 Health News chief Washington correspondent Julie Rovner to discuss these issues and more.

    Listen Now